Videos

ASCP 2026 leaders share practical ways to engage patients in acute psychosis—active listening, noncollusive language, and rapport before assessment.

AI adoption in psychiatry and emerging psychedelic therapies are among the most anticipated topics at ASCP 2026, according to Benjamin Brody, MD.

David W. Goodman, MD, discusses the new ASCP consensus recommendations on when clinicians should consider deprescribing stimulants as part of good ADHD care.

Curiosity, rapport, and understanding lived experience can strengthen schizophrenia care and treatment engagement, according to Tracy Hicks, DNP.

John J. Miller, MD, Psychiatric Times editor in chief, looks forward to learning and sharing the late-breaking science, expert interviews, and new podcast conversations in psychopharmacology.

Psychiatrist Gus Alva highlights new depression therapies, neuromodulation, and why screening for bipolar disorder prevents antidepressant harm.

Learn why insomnia and daytime sleepiness signal psychiatric risk, and how screening for apnea, delayed phase, and fatigue sharpens treatment.

Explore why sexual health matters after 65 and how clinician comfort boosts disclosure.

Unpack gaming, gambling, social media, and exercise addiction, spotlighting comorbid anxiety, withdrawal signs, and harm-reduction treatment.

Digital gaming, gambling, and AI reliance drive emerging behavioral addictions, affecting mood and cognition.

Olanzapine-samidorphan keeps olanzapine efficacy yet limits weight gain, boosts negative symptoms, and cuts ER visits in real-world care.

Explore practical ways psychiatrists address sexual side effects and adjust medication for older adults.

New data from 245K clinicians reveals therapy access roadblocks—and how online scheduling helps patients find available care faster.

How ketamine enhances psychotherapy—and what new psilocybin studies suggest about broader health effects.

Learn more about strategies for deprescribing, and the importance of finding the most effective medication possible.

See how overlooked birth trauma can mimic postpartum depression.

How psychiatric illness shapes cancer care and outcomes.

Learn more about medication use in pregnancy and postpartum, including risks and benefit analysis.

Learn why adult ADHD often hides behind anxiety or depression, how childhood history and family risk guide diagnosis, and why stimulants still matter.

Analysis of speech, acoustics, and facial cues reveals early psychosis and suicide risk.

MRI-guided SAINT TMS aims to remit treatment-resistant depression in days.

Studies link compassion and wisdom to less loneliness and richer gut microbiome diversity, pointing to gut–brain targets for mental health interventions.

Guidance on psychotropic meds in pregnancy: personalize decisions, coordinate care, and plan early to prevent postpartum relapse.

Gut microbiome linked to loneliness, showing compassion-based wisdom may protect mental health over time.

Explore APA sessions on recruiting and retaining psychiatry faculty, assessing intimate partner violence risk, and building leadership skills.

Planning for prevention of perinatal psychiatric relapse with safer medication options.

At APA, Helen Lavretsky spotlights mentorship, trainee research, and integrative mind-body tools to boost resilience and brain health.

Computational phenotyping reveals prodromal psychosis clues, connects biomarkers to symptoms, and shows why stress and cannabis reduction matters.

Discover APA sessions on OCD therapies, gut-brain microbiome insights, AI, sports psychiatry, and geriatric updates from top clinicians.

Psychiatry faces surging stress-driven illness as psychedelics, lifestyle medicine, and biomarkers reshape precision diagnosis and care.